# Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

> **NCT07282587** · PHASE2 · RECRUITING · sponsor: **Jazz Pharmaceuticals** · enrollment: 90 (estimated)

## Conditions studied

- Advanced Pheochromocytoma and Paraganglioma
- PCPG

## Interventions

- **DRUG:** ONC206
- **DRUG:** ONC206: Dose 1
- **DRUG:** ONC206: Dose 2

## Key facts

- **NCT ID:** NCT07282587
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-02
- **Primary completion:** 2028-12-15
- **Final completion:** 2028-12-15
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07282587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07282587, "Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07282587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*